Press releases
-
Dec 15 ,2020
December, 2020 | Source: Gain Therapeutics LUGANO, Switzerland, Dec. 15, 2020 (GLOBE NEWSWIRE) -- GT Gain Therapeutics SA (“Gain”), a subsidiary of Gain Therapeutics, Inc., a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted, along with the Institute for Research in Biomedicine (IRB, affiliated to USI Università della Svizzera Italiana) and the Neurocentro announced today that Innosuisse, the...
Nov 30 ,2020Partnership to investigate Gain’s structurally targeted allosteric regulator candidates (STARs) in cellular models of Gaucher disease and Parkinson’s disease November 30, 2020 09:40 ET | Source: Gain Therapeutics BETHESDA, Md. and BALTIMORE, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain”), today announced a research collaboration with the University of Maryland School of Medicine (UMSOM), to investigate Gain’s structurally targeted allosteric regulators (STARs) in cellular...
Oct 13 ,2020October 13, 2020 08:00 ET | Source: Gain Therapeutics BETHESDA, Md., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (“Gain”) a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted, today announced that it will present an oral poster on its brain penetrant structurally targeted allosteric regulators (STARs) for the treatment of neuronopathic Gaucher disease at the European Working Group on...
In the News
Sep 28 ,2020Treating lysosomal storage disorders: Gain and Sumitomo Dainippon enter partnershipSep 10 ,2020Gain Therapeutics Inc. signs a collaboration with Sumitomo Dainippon Pharma Co. Ltd.Jul 24 ,2020Jeff Capello out the door as Michael McDonnell takes over Biogens CFO post; Ron Bruehlman named interim CFO at IQVIAEvents
January 6-8 & 11-14, 2021January 11-14, 2021December 16th 10:40am – 11:40 am est